Oxford Nanopore Technologies · 17 hours ago
Nanopore Account Executive
United States
Full-time
Remote
Mid, Senior Level
$124K/yr - $155K/yr
5+ years expOxford Nanopore Technologies is seeking a senior, field-based commercial professional to own and expand adoption of Oxford Nanopore sequencing across the Mountain West. This role involves driving growth of the GridION and PromethION platforms and requires strategic account planning and technical fluency in complex scientific sales environments.
BiopharmaBiotechnologyGeneticsHealth DiagnosticsNanotechnology
Responsibilities
Own commercial responsibility for a defined, high-potential territory
Develop and execute strategic account plans to expand instrument placement, drive consumables pull-through and grow long-term customer value
Manage and direct sophisticated sales cycles involving capital equipment, applications development, and ongoing supply agreements
Engage effectively with diverse stakeholder groups including principal investigators, core facility directors, procurement, institutional leadership, and commercial and translational research teams within large biotech and clinical research environments
Develop and grow strategic relationships within large biotech organizations and clinical research-focused institutions, supporting platform adoption for discovery, translational, and pre-clinical research applications
Position Nanopore sequencing effectively within competitive NGS environments by articulating differentiated value and aligning solutions to customer research goals
Build and maintain strong relationships with key customers and influential researchers across a broad range of research disciplines
Coordinate territory activities with Inside Sales Account Manager, Field Applications Scientist, Clinical Sales Specialist, and Marketing colleagues to ensure consistent, high-quality customer engagement
Build and maintain a robust sales pipeline using consultative selling methodologies
Deliver accurate forecasting and maintain timely CRM updates, funnel reporting, and competitive intelligence
Pursue growth opportunities with urgency and discipline, demonstrating resilience and focus within competitive sales situations while working toward clearly defined performance objectives
Participate in and support regional seminars, workshops, and conferences to strengthen Oxford Nanopore’s visibility and scientific credibility within the territory
Participate fully in required training programs and demonstrate proficiency as assessed
Manage administrative responsibilities including expense management, reporting, and adherence to company policies and applicable safety standards
Qualification
Required
Bachelor's degree in Life Sciences or a related field (advanced degree preferred)
Minimum of 5 years of field-based commercial experience, including at least 3 years selling scientific instrumentation, high-technology platforms, or complex laboratory solutions OR relevant inside sales or distribution experience with Oxford Nanopore technology or in the NGS market
Demonstrated success managing complex, consultative sales processes in competitive environments
Strong understanding of the sales cycle, forecasting, and CRM systems
Excellent communication, organization, and time-management skills
Ability to work independently within a matrixed, international organization
Commercially astute, with experience working to budgets and performance targets
Established professional relationships with scientific and operational stakeholders within the assigned territory
Motivated by competition, accountability, and winning business through preparation, insight, and persistence
Benefits
Healthcare benefits
Participate in the company 401(k) plan and company match
Short-term and long-term disability coverage
Basic life insurance
Commuter benefits
Company
Oxford Nanopore Technologies
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore sequencing technology.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.56BKey Investors
Novo HoldingsbioMerieuxM&G Investments
2024-08-01Post Ipo Equity· $63.64M
2023-10-19Post Ipo Equity· $84.95M
2021-09-30IPO
Leadership Team
Gordon Sanghera
Chief Executive Officer, Co - founder
Nicholas Keher
CFO
Recent News
2026-01-17
Company data provided by crunchbase